Fusion protein capable of degrading amyloid beta peptide

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61K 38/48 (2006.01) A61P 25/28 (2006.01) C07K 19/00 (2006.01) C12N 9/64 (2006.01)

Patent

CA 2681404

The present invention relates fusion proteins and their use in enzymatic treatment of Alzheimer's disease patients. Said fusion protein has the formula M-A, capable of degrading amyloid beta peptide at one or more cleavage sites in its amino acid sequence, wherein M is a protein componentthat prolongs the half-life of the fusion protein, and A is a protein component that cleaves the amyloid beta peptide.

L'invention concerne des protéines de fusion et leur utilisation dans le traitement enzymatique des patients souffrant de la maladie d'Alzheimer. La protéine de fusion a la formule M-A, capable de dégrader le peptide bêta-amyloïde à un ou plusieurs sites de clivage dans sa séquence d'acides aminés, M étant un composant de type protéine qui prolonge la demi-vie de la protéine de fusion, et A étant un composant de type protéine qui clive le peptide bêta-amyloïde.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Fusion protein capable of degrading amyloid beta peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fusion protein capable of degrading amyloid beta peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion protein capable of degrading amyloid beta peptide will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1596357

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.